Original Research
Published on 04 Nov 2015
Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2015.00076
- 7,391 views
- 58 citations